SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 1/27/15 Ascendis Pharma A/S F-1MEF 1/27/15 3:90K RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: F-1MEF Registration of Additional Securities HTML 30K 2: EX-5.1 Opinion re: Legality HTML 20K 3: EX-23.1 Consent of Experts or Counsel HTML 6K
EX-23.1 |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form F-1, filed pursuant to Rule 462(b) under the Securities Act of 1933, of our report dated August 1, 2014 (January 16, 2015, as to the effects of the bonus share issuance and the consequential impact on the warrants as described in Note 1), relating to the consolidated financial statements of Ascendis Pharma A/S (which report expresses an unqualified opinion on the financial statements and includes an explanatory paragraph referring to the restatement of the previously issued consolidated financial statements for the year ended December 31, 2013 and substantial doubts over going concern, as described in Note 1), appearing in the Registration Statement on Form F-1 (No. 333-201050).
We also consent to the reference to us under the heading “Experts” in such Registration Statement on Form F-1 (File No. 333-201050).
Deloitte Statsautoriseret Revisionspartnerselskab
Copenhagen, Denmark
/s/ Jens Sejer Pedersen | /s/ Flemming Larsen | |
State Authorised | State Authorised | |
Public Accountant | Public Accountant |
This ‘F-1MEF’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 1/27/15 | |||
1/16/15 | F-1/A | |||
8/1/14 | ||||
12/31/13 | ||||
List all Filings |